Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

This publication has 44 references indexed in Scilit:

• Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Phosphorylation-Dependent Desensitization by Anandamide of Vanilloid Receptor-1 (TRPV1) Function in Rat Skeletal Muscle Arterioles and in Chinese Hamster Ovary Cells Expressing TRPV1
  Molecular Pharmacology, 2006
• A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats
  PAIN®, 2005
• Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats
  Neuropharmacology, 2005
• Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies
  Neuropharmacology, 2005
• The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling
  Journal of Neuroscience, 2005
• The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats
  Neuroscience Letters, 2004
• The endogenous cannabinoid system and its role in nociceptive behavior
  Journal of Neurobiology, 2004
• Endocannabinoids accumulate in spinal cord of SOD1^G93A transgenic mice
  Journal of Neurochemistry, 2004
• Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models
  European Journal of Neuroscience, 2003